MBX Biosciences, Inc. MBX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s deferred tax assets and other non-current assets?
- MBX Biosciences, Inc. (MBX) reported deferred tax assets and other non-current assets of $579K in Q1 2026.
- How has MBX Biosciences, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- MBX Biosciences, Inc.'s deferred tax assets and other non-current assets increased by 1058.0% year-over-year, from $50K to $579K.
- What is the long-term trend for MBX Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s deferred tax assets and other non-current assets has grown at a 176.8% compound annual growth rate (CAGR), from $50K to $383K.